Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The nonspecific clinical presentation of acute hepatitis A (AHA) mandates the detection of anti-hepatitis A virus IgM antibodies (IgM anti-HAV) in the serum for obtaining a definitive diagnosis. However, IgM anti-HAV might not be present during the early phase of the disease. The aim of this study was to determine the optimal time for repeating the IgM anti-HAV test (HAV test) in AHA patients with a negative initial test. Methods: In total, 261patients hospitalized with AHA were enrolled for this retrospective study. AHA was diagnosed when the test for IgM anti-HAV was positive and the serum alanine aminotransferase (ALT) level was ≥400 IU/L. Repeat HAV test was conducted after 1-2 weeks if the initial HAV test was negative but AHA was still clinically suspected. Results: The results of the initial HAV test were negative in 28 (10.7%) patients. The intervals from symptom onset to the initial-HAV-test day and from the peak-ALT day to the initial-HAV-test day were significantly shorter in the negative-initial-HAV-test group, but on multivariate analysis only the latter was significantly associated with negative results for the initial HAV test (β=-0.978;odds ratio [95% confidence interval]=0.376 [0.189-0.747]; P=0.005). The HAV test was positive in all patients when it was performed at least 2 days after the peak-ALT day. Conclusions: The results of HAV tests were significantly associated with the interval from the peak-ALT day to the HAV-test day. The optimal time for repeating the HAV test in clinically suspicious AHA patients with a negative initial HAV test appears to be at least 2 days after the peak-ALT day. (Korean J Hepatol 2012;18:56-62)
Abstract
Background/Aims: The nonspecific clinical presentation of acute hepatitis A (AHA) mandates the detection of anti-hepatitis A virus IgM antibodies (IgM anti-HAV) in the serum for obtaining a definitive diagnosis. However, IgM anti-HAV might not be present during the early phase of the disease. The aim of this study was to determine the optimal time for repeating the IgM anti-HAV test (HAV test) in AHA patients with a negative initial test. Methods: In total, 261patients hospitalized with AHA were enrolled for this retrospective study. AHA was diagnosed when the test for IgM anti-HAV was positive and the serum alanine aminotransferase (ALT) level was ≥400 IU/L. Repeat HAV test was conducted after 1-2 weeks if the initial HAV test was negative but AHA was still clinically suspected. Results: The results of the initial HAV test were negative in 28 (10.7%) patients. The intervals from symptom onset to the initial-HAV-test day and from the peak-ALT day to the initial-HAV-test day were significantly shorter in the negative-initial-HAV-test group, but on multivariate analysis only the latter was significantly associated with negative results for the initial HAV test (β=-0.978;odds ratio [95% confidence interval]=0.376 [0.189-0.747]; P=0.005). The HAV test was positive in all patients when it was performed at least 2 days after the peak-ALT day. Conclusions: The results of HAV tests were significantly associated with the interval from the peak-ALT day to the HAV-test day. The optimal time for repeating the HAV test in clinically suspicious AHA patients with a negative initial HAV test appears to be at least 2 days after the peak-ALT day. (Korean J Hepatol 2012;18:56-62)
참고문헌 (13)
- 강형민, "단일 병원에서 경험한 최근 급성 바이러스간염의 원인 및 임상 양상", Clinical and Molecular Hepatology, 13(4), pp.495~502 (2007), 대한간학회
- 문장식, "최근 3년간 서울 지역 단일기관에서 급성 바이러스 간염의 원인", 대한내과학회지, 74(6), pp.624~631 (2008), 대한내과학회
- Sjogren MH, "Hepatitis A, In Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 9th ed", pp.1279~1285 (2010), Saunders Elsevier
- Lemon SM, "Type A viral hepatitis: epidemiology, diagnosis, and prevention", Clin Chem, 43, pp.1494~1499 (1997)
- Liaw YF, "Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak", Infection, 14, pp.156~158 (1986)
- Kao HW, "The persistence of hepatitis A IgM antibody after acute clinical hepatitis A", Hepatology, 4, pp.933~936 (1984)
- 이응준, "최근 2년간 발생한 급성 A형간염의 임상 특성에 관한 연구", 대한소화기학회지, 52(5), pp.298~303 (2008), 대한소화기학회
- Jung SW, "Factors for Predicting Positive Results for Anti-HAV IgM Retesting Among Initially Seronegative Patients", DIGESTIVE DISEASES AND SCIENCES, 55(12), pp.3537~3540 (2010), SPRINGER
- Sherlock S, "Viral hepatitis: general features, hepatitis A, hepatitis E and other viruses, In Deases of the Liver and Biliary System, 11th ed", pp.267~283 (2002), Blackwell Science
- Oren R, "Detection of hepatitis A virus RNA in serum from patients with acute hepatitis", J Med Virol, 28, pp.261~263 (1989)
- Yotsuyanagi H, "Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction", J Med Virol, 40, pp.35~38 (1993)
- Jung YM, "Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea", J Med Virol, 82, pp.1318~1326 (2010)
- Yoon YK, "Epidemiological and genetic analysis of a sustained communitywide outbreak of hepatitis A in the Republic of Korea, 2008: a hospital-based case-control study", J Clin Virol, 46, pp.184~188 (2009)